Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Unknown 2Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 64Other hematologic neoplasm 34Gastrointestinal 10Plasma cell 7CNS 7Thoracic 3Sarcoma 3Other solid neoplasm 3Head & Neck 3Gynecologic 3Breast 3Dermatologic 2Myeloid 1Genitourinary 1Classical hematology 1

Conditions

Solid Tumor 1Nectin4-positive Advanced Malignant Solid Tumor 1Mesothelioma, Malignant 1

Interventions

Cisplatin 60Carboplatin 55Cyclophosphamide 47Pemetrexed 45Irinotecan 33pembrolizumab 32Paclitaxel 29Etoposide 29Gemcitabine 28Nivolumab 24Bevacizumab 24Interviews as Topic 23Vincristine 22Capecitabine 22Topotecan 20Filgrastim 20Early Intervention, Educational 20fludarabine 19Oxaliplatin 19Docetaxel 19Specimen Handling 18Drug Therapy 18Temozolomide 17Sorafenib 17Leucovorin 17Everolimus 17Educational Status 17Radiotherapy 16Methods 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Immunotherapy, Adoptive × Other solid neoplasm × Clear all
NCT04577326 2025-07-25

Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma

Memorial Sloan Kettering Cancer Center

Phase 1 Active not recruiting
14 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT05748938 2023-03-01

A Study of RD14-01 in Patients With Advanced Solid Tumors

920th Hospital of Joint Logistics Support Force of People's Liberation Army of China

Phase 1/2 Unknown
12 enrolled
Other solid neoplasm

Solid Tumor

NCT03932565 2020-11-18

Interventional Therapy Sequential With the Fourth-generation CAR-T Targeting Nectin4/FAP for Malignant Solid Tumors

The Sixth Affiliated Hospital of Wenzhou Medical University

Phase 1 Unknown
30 enrolled
Other solid neoplasm

Nectin4-positive Advanced Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡